Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the record history and the previous v3.3.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:39:00.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.3.3' to the Record History. Removed the 'HHS Vulnerability Disclosure' footer link and the older revision 'Revision: v3.3.2' from the page.
    Difference
    0.2%
    Check dated 2025-12-23T21:24:40.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Record History now lists Revision v3.3.2 and removes Revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:57:16.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The operating-status notice about government funding was removed from the page.
    Difference
    0.7%
    Check dated 2025-11-18T07:11:39.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The screenshots show the Record History page for NCT02183870 with version entries from 2014 to 2022. The content and structure remain consistent, with only minor UI updates.
    Difference
    0.1%
    Check dated 2025-11-03T21:13:52.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).
    Difference
    12%
    Check dated 2025-10-06T06:52:55.000Z thumbnail image

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.